Regeneron Pharmaceuticals Incorporated operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Regeneron Pharmaceuticals Incorporated with three other
companies in this sector in UNITED STATES :
sales of $6.26 billion
of which 51%
Daiichi Sankyo Company Limited
of which 93%
was Prescription drugs), and
of which 84%
was CSL Behring).
Regeneron Pharmaceuticals Incorporated reported sales of $7.86 billion
December of 2019.
increase of 17.2%
versus 2018, when the company's sales were $6.71 billion.
Sales at Regeneron Pharmaceuticals Incorporated have increased during each of the previous five years
(and since 2014, sales have increased a total of 179%).